Blogs

Aug 31, 2017
Applied Clinical Trials
What cannot have escaped the attention of any impartial observer is that Milan is one of the leading contenders to host the EMA and that Tajani and Rasi are both Italian. The EMA relocation is a hot topic without any bias towards Milan.
Aug 25, 2017
Applied Clinical Trials
The National Institutes of Health (NIH) focuses on developing strategies that will encourage further research to support safe and effective therapies for pregnant and lactating women.
Aug 24, 2017
Applied Clinical Trials
This article discusses best practices and benefits of keeping a trial top of mind at global sites, and measuring some of the qualitative and quantitative impacts it can have on a trial.
Aug 23, 2017
Applied Clinical Trials
As the clinical trials industry starts to incorporate mHealth initiatives into their trials, study teams now have to determine the extent of their ICF consent forms during study deployment, and how to cover mHealth activities within these forms.
Aug 07, 2017
Applied Clinical Trials
The release of the ICH E6 R2 guidance, which outlines a new approach to clinical trials operations, will have a major impact on the industry, writes Patrick Hughes.
Aug 04, 2017
Applied Clinical Trials
In this interview, we speak to Dr. Joanne Waldstreicher, Chief Medical Officer of J&J’s Office of the Chief Medical Officer (OCMO), to discuss its data sharing program via the Yale University Open Data Access (YODA) Project.
Aug 02, 2017
Applied Clinical Trials
How can manufacturers ensure their clinical trial methods are evolving along with their product portfolio? It starts by taking a patient-focused approach to trial design, writes Susan Weidner.
Aug 02, 2017
Applied Clinical Trials
Of the 28 European Union member states, nine did not make an offer to host the European Medicines Agency (EMA) by the July 31 deadline—and one of them is very sorely missed, writes Peter O'Donnell.
Jul 27, 2017
Applied Clinical Trials
With the rise in deaths, injuries, and treatment costs related to the abuse and misuse of opioid painkillers, the biomedical research community is seeking more effective and informative methods for testing and evaluating new pain medicines. Jill Wechsler reports.
Jul 26, 2017
Applied Clinical Trials
Jill Wechsler discusses the importance of clinical trial participants and the challenges FDA faces in expanding patient engagement.
native1_300x100
lorem ipsum